Heart:接受外科冠脉手术的先心病患者远期生存率尚可

2018-08-30 MedSci MedSci原创

目前,关于先心病患者接受冠脉外科手术的临床资料十分有限,本研究的目的旨在回顾先心病接受冠脉手术的适应症和预后。本研究纳入了数据库中1982年至2011年接受外科冠脉手术的年龄小于18岁的先心病患者137例,其中冠脉搭桥占72例(平均年龄6.8岁),其他手术操作占65例(平均年龄2.6岁)。大部分冠脉手术与主动脉根部疾病(61.3%)或冠脉畸形(27.7%)有关,其他原因的占10.9%。总共有20例

目前,关于先心病患者接受冠脉外科手术的临床资料十分有限,本研究的目的旨在回顾先心病接受冠脉手术的适应症和预后。

本研究纳入了数据库中1982年至2011年接受外科冠脉手术的年龄小于18岁的先心病患者137例,其中冠脉搭桥占72例(平均年龄6.8岁),其他手术操作占65例(平均年龄2.6岁)。大部分冠脉手术与主动脉根部疾病(61.3%)或冠脉畸形(27.7%)有关,其他原因的占10.9%。总共有20例院内死亡,对54例存活至出院后的患者进行随访分析发现,患者15年的非移植存活率为91%。

研究结果显示,接受有冠脉手术的先心病患儿中远期生存率尚可,预后与患者的临床指征相关。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1256675, encodeId=44e812566e5cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311483, encodeId=5ca313114831a, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356907, encodeId=ef03135690e6f, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562964, encodeId=43471562964ad, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1256675, encodeId=44e812566e5cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311483, encodeId=5ca313114831a, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356907, encodeId=ef03135690e6f, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562964, encodeId=43471562964ad, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 ssnine
  3. [GetPortalCommentsPageByObjectIdResponse(id=1256675, encodeId=44e812566e5cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311483, encodeId=5ca313114831a, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356907, encodeId=ef03135690e6f, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562964, encodeId=43471562964ad, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1256675, encodeId=44e812566e5cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69009, encryptionId=43706900963, topicName=生存率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311483, encodeId=5ca313114831a, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356907, encodeId=ef03135690e6f, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562964, encodeId=43471562964ad, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Sep 01 07:52:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 slcumt

相关资讯

JACC:肌钙蛋白I可预测COPD患者心血管疾病风险

慢性阻塞性肺疾病(COPD)患者发生心血管疾病的风险也会增高。本研究的目的旨在评估COPD患者肌钙蛋白I的水平与心血管疾病的相关性。本次随机双盲对照试验将16485名COPD伴心血管疾病或风险的患者随机分成安慰剂组、每天吸入糠酸氟替卡松组、维拉特罗组或两者均吸入的复合组。并对1599名患者的血浆高敏肌钙蛋白I水平进行检测。分析结果显示,有1542名(96%)患者的基础血浆高敏肌钙蛋白I水平超过了测

JAHA:维生素K拮抗剂的摄入会增加心血管疾病风险

既往研究显示,维生素K拮抗剂(VKA)的使用与血管结构和功能的损伤相关,本研究的目的旨在评估VKA的摄入与不同类型心血管疾病发生的相关性。本研究纳入了15010名35岁至74岁的研究对象,包括287名VKA使用者和14564名非VKA使用者。多变量分析结果显示,VKA的摄入与硬化指数(β=+2.54 m/s; [0.41/4.66]; P=0.019)、踝肱指数(β=−0.03; [−0.04/−

JAHA:孕龄与出生体重对先心病婴幼儿死亡率的影响

患有严重先天性心脏病(CCHD)的胎儿孕龄(GA)常常更小,本研究的目的旨在评估出生体重Z评分对早产儿(GA<37周)、较早产儿(GA 37-38周)和足月产儿(GA 39-42周)一年内死亡率的影响。 本研究纳入了2007-2012年加利福尼亚州的CCHD且GA在22-42周的新生儿,主要终点事件是1年死亡率。最终,共纳入了6903名CCHD患儿,对于早产和足月产儿,只有出生Z评分<-2才

J Gernonto:肌肉力量弱的人更易早逝?

根据美国密歇根大学的一项新研究,肌肉力量弱的人通常不如强壮的人寿命长。

JACC:肺功能的下降会增加心血管疾病风险

肺功能不全会增加心血管疾病(CVD)的发生风险。本研究的目的旨在评估肺功能的纵向下降是否与心衰、冠心病和卒中的发生相关。本研究纳入了ARIC 临床研究中的10351名无CVD的参与者,平均年龄为54 ± 6岁,女性占56%,白种人占81%。快速肺功能下降定义为1s用力呼气量(FEV1)或用力肺活量(FVC)下降的最大四分位数(n=2585)。经过平均17 ± 6年时间的随访,心衰的发生率为14%,

JAHA:GWTG‐HF评分对出院后心衰患者的评估作用

GWTG‐HF危险评分是由美国心脏病学会制定的用来评估急性心衰患者住院死亡率的评分体系,本研究的目的旨在评估GWTG‐HF危险评分对出院心衰病人预后的作用。本研究纳入了1452名接受有GWTG‐HF危险评分的心衰患者,并将其分成三组(低分组、中等分组和高分组)。血浆B型钠尿肽水平在高分组中明显升高(平均的B型钠尿肽水平在低分组、中等分组和高分组中分别为167.0、260.7 和418.2 pg/m